Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Time dependency of outcomes for drug-eluting vs bare-metal stents.

Leung AA, Southern DA, Galbraith PD, Knudtson ML, Philpott AC, Ghali WA; APPROACH Investigators.

Can J Cardiol. 2013 Dec;29(12):1616-22. doi: 10.1016/j.cjca.2013.09.003.

PMID:
24267804
2.

Niacin improves lipid profile but not endothelial function in patients with coronary artery disease on high dose statin therapy.

Philpott AC, Hubacek J, Sun YC, Hillard D, Anderson TJ.

Atherosclerosis. 2013 Feb;226(2):453-8. doi: 10.1016/j.atherosclerosis.2012.10.067. Epub 2012 Nov 5.

PMID:
23174368
3.

Comparison of new measures of vascular function to flow mediated dilatation as a measure of cardiovascular risk factors.

Philpott AC, Lonn E, Title LM, Verma S, Buithieu J, Charbonneau F, Anderson TJ.

Am J Cardiol. 2009 Jun 1;103(11):1610-5. doi: 10.1016/j.amjcard.2009.01.376. Epub 2009 Apr 8.

PMID:
19463524
4.

Long-term outcomes of patients receiving drug-eluting stents.

Philpott AC, Southern DA, Clement FM, Galbraith PD, Traboulsi M, Knudtson ML, Ghali WA; APPROACH Investigators.

CMAJ. 2009 Jan 20;180(2):167-74. doi: 10.1503/cmaj.080050. Epub 2008 Dec 18.

5.

Temporal trends in major angioplasty complications: technical issues and the case for on-site coronary surgery.

Mishra KJ, Sage PR, Philpott AC, Zeitz CJ, Horowitz JD.

Intern Med J. 2006 Jul;36(7):458-61.

PMID:
16780454
6.

Aldehyde dehydrogenase, nitric oxide synthase and superoxide in ex vivo nitrate tolerance in rat aorta.

de la Lande IS, Stepien JM, Philpott AC, Hughes PA, Stafford I, Horowitz JD.

Eur J Pharmacol. 2004 Aug 2;496(1-3):141-9.

PMID:
15288585
7.

A new method for assaying antimicrobials in the prostate.

Philpott AC, Crawford ED, Miller GJ.

Infection. 1991;19 Suppl 3:S150-3.

PMID:
2055651

Supplemental Content

Loading ...
Support Center